Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ApoPharma's Preemptive Safety Strategy For Ferriprox Includes Centralized Pharmacy Distribution

This article was originally published in The Pink Sheet Daily

Executive Summary

ODAC will consider Ferriprox (deferiprone) as second-line treatment for transfusional iron overload; the company hopes for an endorsement of its patient and provider registries as well.
Advertisement

Related Content

Affymax's Peginesatide May Be Tough Sell To ODAC As ESAs Cast Long Showdow
ApoPharma's Ferriprox Clears FDA, But Needs Cardiac Safety Study
ApoPharma's Ferriprox Clears FDA, But Needs Cardiac Safety Study
ApoPharma's Ferriprox Gamble Pays Off In Panel Vote, But What About FDA?
ApoPharma's Ferriprox Gamble Pays Off In Panel Vote, But What About FDA?
Ferraprox Advisory Cmte: Can Risk Management Overcome Safety, Dosing Worries?
Ferraprox Advisory Cmte: Can Risk Management Overcome Safety, Dosing Worries?
AstraZeneca's Vandetanib Approval Includes REMS With Distribution Restrictions

Topics

Advertisement
UsernamePublicRestriction

Register

PS072760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel